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Note: defective and normal functioning LDLR appear
















Note: only normal functioning LDLR appear
at the cell surface (at a lesser degree)
Het. Class I or II defect in FH


















Germany).  PCR  products  of  LDLR  exons  with  aberrant 





The  index  family  is  a  Turkish  family  with  two  identi-

























































Patients Sex Age (years) TC (mmol/L) TG (mmol/L) LDL-C (mmol/L) HDL-C (mmol/L) LDLR (p.W556R)
No lipid-lowering therapy M 36 9.8 1.7 7.7 1.2 Heteroz
Simvastatin 40 mg/ezetimibe 10 mg 5.2 1.1 3.5 1.1
No lipid-lowering therapy F 30 7.6 1.3 5.2 1.8 Heteroz





















2.    The  LDL  cholesterol-lowering  potency  of  simvastatin 
40 mg/ezetimibe 10 mg was impressive in both subjects. 









This  underlines  the  heterogeneity  in  hyperlipidemic 
patients and the need of appropriate knowledge of the 
primary defects.








whereas  simvastatin  40  mg/ezetimibe  10  mg  provides  a 
decrease in LDL cholesterol of − 55%.
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